Carlos Quintanilla-Bordás

7PUBLICATIONS
10CO-AUTHORS
Immunogenetics (incl. genetic immunology)Medical infection agents (incl. prions)Neurology and neuromuscular diseasesPharmacology and pharmaceutical sciences not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 15, 2026
An algorithm to predict intrathecal IgM synthesis in multiple sclerosis patients: optimizing the use of oligoclonal band testing.

|Dec 18, 2024
Dynamic 18 F-FDG PET to detect differences among patients with progressive and relapsing multiple sclerosis: a pilot study.

Carlos Quintanilla-Bordás, Matías Fernández-Patón, Amadeo Ten

|Sep 22, 2024
Renal function's impact on serum neurofilament levels in patients with multiple sclerosis: an exploratory analysis.

Jordi Tortosa-Carreres, Laura Cubas-Núñez, Maria Teresa Sanz

|Feb 02, 2022
Effectiveness of rituximab vs. ocrelizumab for the treatment of primary progressive multiple sclerosis: a real-world observational study.

Carmen Alcalá, Carlos Quintanilla-Bordás, Francisco Gascón

|Jan 21, 2022
Escalation vs. Early Intense Therapy in Multiple Sclerosis.

Bonaventura Casanova, Carlos Quintanilla-Bordás, Francisco Gascón

|Nov 17, 2019
Functional and structural changes in the visual pathway in multiple sclerosis.

María Carcelén-Gadea, Carlos Quintanilla-Bordás, Alicia Gracia-García

Pageof 2

Frequent Collaborators

3 joint publications

Bonaventura Casanova

2 joint publications

Jordi Tortosa-Carreres

2 joint publications

Sara Carratalá-Boscá

2 joint publications

Francisco Pérez-Miralles